Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Oyster Point Pharma, Inc. (OYST)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenue:          
Product revenue, net  5.64.7      
   
License revenue - related party          
    Total revenue  5.64.72.76.617.9   
            Total revenue growth  -68.8%       
Cost of product revenue  1.31.30.3     
   
Operating expenses:          
Sales and marketing  22.128.127.0 18.26.24.6 
General and administrative  12.114.012.9-16.110.39.18.50.7
Research and development  3.94.74.75.56.26.75.811.7
    Total operating expenses  38.246.844.644.034.722.018.922.2
    Loss from operations  -33.9-43.4-42.2-38.9-16.8-22.0-18.9-22.2
            Operating margin  -606.6%-924.5%-1561.1%-590.4%-93.5%   
   
Other (expense) income, net          
Interest expense  -3.5-3.2-3.1-2.6-1.1   
Other income (expense), net  0.7-3.4-2.6-0.30.20.00.0 
    Total other (expense) income, net  -2.8-6.6-5.7-3.1-0.90.00.00.0
Comprehensive loss  -36.7-49.9 58.6-17.7-22.0 48.3
    Net loss  -36.7-49.9-47.9-42.1-17.7-22.0-18.9-22.2
   
Net loss per share, basic (in dollars per share)  ($1.37)($1.87)($1.80)($1.62)($0.68)($0.85)($0.73)($0.87)
Net loss per share, diluted (in dollars per share)  ($1.37)($1.87)($1.80)($1.62)($0.68)($0.85)($0.73)($0.87)
   
Weighted average shares outstanding, basic (in shares)  26.826.726.626.026.026.025.924.1
Weighted average shares outstanding, diluted (in shares)  26.826.726.626.026.026.025.924.1
   
Product revenue, net [Extensible Enumeration]          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy